Loading…

Characterizing Discrete Subsets of Polycystic Ovary Syndrome as Defined by the Rotterdam Criteria: The Impact of Weight on Phenotype and Metabolic Features

Context: The Rotterdam criteria for polycystic ovary syndrome (PCOS) defines discrete subgroups whose phenotypes are not yet clear. Objective: The phenotypic characteristics of women in the PCOS subgroups defined by the Rotterdam criteria were compared. Design: The study was observational. Setting:...

Full description

Saved in:
Bibliographic Details
Published in:The journal of clinical endocrinology and metabolism 2006-12, Vol.91 (12), p.4842-4848
Main Authors: Welt, C. K., Gudmundsson, J. A., Arason, G., Adams, J., Palsdottir, H., Gudlaugsdottir, G., Ingadottir, G., Crowley, W. F.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c401t-e3d25736b2baf9660ae8761fd06ce2260d155757677a63ca481c75df217200fa3
cites
container_end_page 4848
container_issue 12
container_start_page 4842
container_title The journal of clinical endocrinology and metabolism
container_volume 91
creator Welt, C. K.
Gudmundsson, J. A.
Arason, G.
Adams, J.
Palsdottir, H.
Gudlaugsdottir, G.
Ingadottir, G.
Crowley, W. F.
description Context: The Rotterdam criteria for polycystic ovary syndrome (PCOS) defines discrete subgroups whose phenotypes are not yet clear. Objective: The phenotypic characteristics of women in the PCOS subgroups defined by the Rotterdam criteria were compared. Design: The study was observational. Setting: Subjects were studied in an outpatient setting in Boston and Reykjavik. Patients: Four subgroups of subjects with PCOS defined by 1) irregular menses (IM), hyperandrogenism (HA), and polycystic ovary morphology (PCOM, n = 298); 2) IM/HA (n = 7); 3) HA/PCOM (n = 77); and 4) IM/PCOM (n = 36) and a group of controls (n = 64), aged 18–45 yr, were examined. Intervention: Subjects underwent a physical exam; fasting blood samples for androgens, gonadotropins, and metabolic parameters; and a transvaginal ultrasound. Main Outcome Measures: The phenotype was compared between groups. Results: Ninety-seven percent of women with IM/HA had PCOM. Therefore, the groups with and without PCOM were combined. The Ferriman-Gallwey score and androgen levels were highest in the hyperandrogenic groups (IM/HA and HA/PCOM), whereas ovarian volume was higher in all PCOS subgroups compared with controls, as expected based on the definitions of the PCOS subgroups. Body mass index and insulin levels were highest in the IM/HA subgroup. Conclusions: Subjects with PCOS defined by IM/HA are the most severely affected women on the basis of androgen levels, ovarian volumes, and insulin levels. Their higher body mass index partially accounts for the increased insulin levels, suggesting that weight gain exacerbates the symptoms of PCOS.
doi_str_mv 10.1210/jc.2006-1327
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68224401</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68224401</sourcerecordid><originalsourceid>FETCH-LOGICAL-c401t-e3d25736b2baf9660ae8761fd06ce2260d155757677a63ca481c75df217200fa3</originalsourceid><addsrcrecordid>eNptkc1u1DAYRS1ERYfCjjXyBlak-CexM-yqKYVKrVrRIthZjv2lk1FiB9tBCq_Sl8XRjNRNV7aso3utcxF6R8kpZZR83plTRogoKGfyBVrRdVkVkq7lS7QihNFiLdnvY_Q6xh0htCwr_godU0kIJ3W1Qo-brQ7aJAjdv8494PMumgAJ8N3UREgR-xbf-n42c0ydwTd_dZjx3exs8ANgHfE5tJ0Di5sZpy3gHz7lLKsHvAndkqq_4Pv8fjmMuWVJ-wXdwzbfHL7dgvNpHnOOs_gakm58n0suQKcpQHyDjlrdR3h7OE_Qz4uv95vvxdXNt8vN2VVhSkJTAdyySnLRsEa3ayGIhloK2loiDDAmiKVVJSsppNSCG13W1MjKtozKLK7V_AR93OeOwf-ZICY1ZAvQ99qBn6ISNWNlrsrgpz1ogo8xQKvG0A3ZiKJELWOonVHLGGoZI-PvD7lTM4B9gg_2M_DhAOhodN8G7UwXn7ia5z_zJYjvOXDWm5B9j1lPVDs_BZfNPF__H27dpFY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68224401</pqid></control><display><type>article</type><title>Characterizing Discrete Subsets of Polycystic Ovary Syndrome as Defined by the Rotterdam Criteria: The Impact of Weight on Phenotype and Metabolic Features</title><source>Oxford Journals Online</source><creator>Welt, C. K. ; Gudmundsson, J. A. ; Arason, G. ; Adams, J. ; Palsdottir, H. ; Gudlaugsdottir, G. ; Ingadottir, G. ; Crowley, W. F.</creator><creatorcontrib>Welt, C. K. ; Gudmundsson, J. A. ; Arason, G. ; Adams, J. ; Palsdottir, H. ; Gudlaugsdottir, G. ; Ingadottir, G. ; Crowley, W. F.</creatorcontrib><description>Context: The Rotterdam criteria for polycystic ovary syndrome (PCOS) defines discrete subgroups whose phenotypes are not yet clear. Objective: The phenotypic characteristics of women in the PCOS subgroups defined by the Rotterdam criteria were compared. Design: The study was observational. Setting: Subjects were studied in an outpatient setting in Boston and Reykjavik. Patients: Four subgroups of subjects with PCOS defined by 1) irregular menses (IM), hyperandrogenism (HA), and polycystic ovary morphology (PCOM, n = 298); 2) IM/HA (n = 7); 3) HA/PCOM (n = 77); and 4) IM/PCOM (n = 36) and a group of controls (n = 64), aged 18–45 yr, were examined. Intervention: Subjects underwent a physical exam; fasting blood samples for androgens, gonadotropins, and metabolic parameters; and a transvaginal ultrasound. Main Outcome Measures: The phenotype was compared between groups. Results: Ninety-seven percent of women with IM/HA had PCOM. Therefore, the groups with and without PCOM were combined. The Ferriman-Gallwey score and androgen levels were highest in the hyperandrogenic groups (IM/HA and HA/PCOM), whereas ovarian volume was higher in all PCOS subgroups compared with controls, as expected based on the definitions of the PCOS subgroups. Body mass index and insulin levels were highest in the IM/HA subgroup. Conclusions: Subjects with PCOS defined by IM/HA are the most severely affected women on the basis of androgen levels, ovarian volumes, and insulin levels. Their higher body mass index partially accounts for the increased insulin levels, suggesting that weight gain exacerbates the symptoms of PCOS.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/jc.2006-1327</identifier><identifier>PMID: 17003085</identifier><identifier>CODEN: JCEMAZ</identifier><language>eng</language><publisher>Bethesda, MD: Endocrine Society</publisher><subject>Adolescent ; Adult ; Androgens - blood ; Biological and medical sciences ; Body Mass Index ; Body Weight - physiology ; Endocrinopathies ; Female ; Fundamental and applied biological sciences. Psychology ; Gonadotropins - blood ; Hormones - blood ; Humans ; Medical sciences ; Metabolic Syndrome - blood ; Metabolic Syndrome - epidemiology ; Metabolism - physiology ; Middle Aged ; Phenotype ; Physical Examination ; Polycystic Ovary Syndrome - classification ; Vertebrates: endocrinology</subject><ispartof>The journal of clinical endocrinology and metabolism, 2006-12, Vol.91 (12), p.4842-4848</ispartof><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c401t-e3d25736b2baf9660ae8761fd06ce2260d155757677a63ca481c75df217200fa3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18367737$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17003085$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Welt, C. K.</creatorcontrib><creatorcontrib>Gudmundsson, J. A.</creatorcontrib><creatorcontrib>Arason, G.</creatorcontrib><creatorcontrib>Adams, J.</creatorcontrib><creatorcontrib>Palsdottir, H.</creatorcontrib><creatorcontrib>Gudlaugsdottir, G.</creatorcontrib><creatorcontrib>Ingadottir, G.</creatorcontrib><creatorcontrib>Crowley, W. F.</creatorcontrib><title>Characterizing Discrete Subsets of Polycystic Ovary Syndrome as Defined by the Rotterdam Criteria: The Impact of Weight on Phenotype and Metabolic Features</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>Context: The Rotterdam criteria for polycystic ovary syndrome (PCOS) defines discrete subgroups whose phenotypes are not yet clear. Objective: The phenotypic characteristics of women in the PCOS subgroups defined by the Rotterdam criteria were compared. Design: The study was observational. Setting: Subjects were studied in an outpatient setting in Boston and Reykjavik. Patients: Four subgroups of subjects with PCOS defined by 1) irregular menses (IM), hyperandrogenism (HA), and polycystic ovary morphology (PCOM, n = 298); 2) IM/HA (n = 7); 3) HA/PCOM (n = 77); and 4) IM/PCOM (n = 36) and a group of controls (n = 64), aged 18–45 yr, were examined. Intervention: Subjects underwent a physical exam; fasting blood samples for androgens, gonadotropins, and metabolic parameters; and a transvaginal ultrasound. Main Outcome Measures: The phenotype was compared between groups. Results: Ninety-seven percent of women with IM/HA had PCOM. Therefore, the groups with and without PCOM were combined. The Ferriman-Gallwey score and androgen levels were highest in the hyperandrogenic groups (IM/HA and HA/PCOM), whereas ovarian volume was higher in all PCOS subgroups compared with controls, as expected based on the definitions of the PCOS subgroups. Body mass index and insulin levels were highest in the IM/HA subgroup. Conclusions: Subjects with PCOS defined by IM/HA are the most severely affected women on the basis of androgen levels, ovarian volumes, and insulin levels. Their higher body mass index partially accounts for the increased insulin levels, suggesting that weight gain exacerbates the symptoms of PCOS.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Androgens - blood</subject><subject>Biological and medical sciences</subject><subject>Body Mass Index</subject><subject>Body Weight - physiology</subject><subject>Endocrinopathies</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gonadotropins - blood</subject><subject>Hormones - blood</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Metabolic Syndrome - blood</subject><subject>Metabolic Syndrome - epidemiology</subject><subject>Metabolism - physiology</subject><subject>Middle Aged</subject><subject>Phenotype</subject><subject>Physical Examination</subject><subject>Polycystic Ovary Syndrome - classification</subject><subject>Vertebrates: endocrinology</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNptkc1u1DAYRS1ERYfCjjXyBlak-CexM-yqKYVKrVrRIthZjv2lk1FiB9tBCq_Sl8XRjNRNV7aso3utcxF6R8kpZZR83plTRogoKGfyBVrRdVkVkq7lS7QihNFiLdnvY_Q6xh0htCwr_godU0kIJ3W1Qo-brQ7aJAjdv8494PMumgAJ8N3UREgR-xbf-n42c0ydwTd_dZjx3exs8ANgHfE5tJ0Di5sZpy3gHz7lLKsHvAndkqq_4Pv8fjmMuWVJ-wXdwzbfHL7dgvNpHnOOs_gakm58n0suQKcpQHyDjlrdR3h7OE_Qz4uv95vvxdXNt8vN2VVhSkJTAdyySnLRsEa3ayGIhloK2loiDDAmiKVVJSsppNSCG13W1MjKtozKLK7V_AR93OeOwf-ZICY1ZAvQ99qBn6ISNWNlrsrgpz1ogo8xQKvG0A3ZiKJELWOonVHLGGoZI-PvD7lTM4B9gg_2M_DhAOhodN8G7UwXn7ia5z_zJYjvOXDWm5B9j1lPVDs_BZfNPF__H27dpFY</recordid><startdate>20061201</startdate><enddate>20061201</enddate><creator>Welt, C. K.</creator><creator>Gudmundsson, J. A.</creator><creator>Arason, G.</creator><creator>Adams, J.</creator><creator>Palsdottir, H.</creator><creator>Gudlaugsdottir, G.</creator><creator>Ingadottir, G.</creator><creator>Crowley, W. F.</creator><general>Endocrine Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20061201</creationdate><title>Characterizing Discrete Subsets of Polycystic Ovary Syndrome as Defined by the Rotterdam Criteria: The Impact of Weight on Phenotype and Metabolic Features</title><author>Welt, C. K. ; Gudmundsson, J. A. ; Arason, G. ; Adams, J. ; Palsdottir, H. ; Gudlaugsdottir, G. ; Ingadottir, G. ; Crowley, W. F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c401t-e3d25736b2baf9660ae8761fd06ce2260d155757677a63ca481c75df217200fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Androgens - blood</topic><topic>Biological and medical sciences</topic><topic>Body Mass Index</topic><topic>Body Weight - physiology</topic><topic>Endocrinopathies</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gonadotropins - blood</topic><topic>Hormones - blood</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Metabolic Syndrome - blood</topic><topic>Metabolic Syndrome - epidemiology</topic><topic>Metabolism - physiology</topic><topic>Middle Aged</topic><topic>Phenotype</topic><topic>Physical Examination</topic><topic>Polycystic Ovary Syndrome - classification</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Welt, C. K.</creatorcontrib><creatorcontrib>Gudmundsson, J. A.</creatorcontrib><creatorcontrib>Arason, G.</creatorcontrib><creatorcontrib>Adams, J.</creatorcontrib><creatorcontrib>Palsdottir, H.</creatorcontrib><creatorcontrib>Gudlaugsdottir, G.</creatorcontrib><creatorcontrib>Ingadottir, G.</creatorcontrib><creatorcontrib>Crowley, W. F.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Welt, C. K.</au><au>Gudmundsson, J. A.</au><au>Arason, G.</au><au>Adams, J.</au><au>Palsdottir, H.</au><au>Gudlaugsdottir, G.</au><au>Ingadottir, G.</au><au>Crowley, W. F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterizing Discrete Subsets of Polycystic Ovary Syndrome as Defined by the Rotterdam Criteria: The Impact of Weight on Phenotype and Metabolic Features</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2006-12-01</date><risdate>2006</risdate><volume>91</volume><issue>12</issue><spage>4842</spage><epage>4848</epage><pages>4842-4848</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><coden>JCEMAZ</coden><abstract>Context: The Rotterdam criteria for polycystic ovary syndrome (PCOS) defines discrete subgroups whose phenotypes are not yet clear. Objective: The phenotypic characteristics of women in the PCOS subgroups defined by the Rotterdam criteria were compared. Design: The study was observational. Setting: Subjects were studied in an outpatient setting in Boston and Reykjavik. Patients: Four subgroups of subjects with PCOS defined by 1) irregular menses (IM), hyperandrogenism (HA), and polycystic ovary morphology (PCOM, n = 298); 2) IM/HA (n = 7); 3) HA/PCOM (n = 77); and 4) IM/PCOM (n = 36) and a group of controls (n = 64), aged 18–45 yr, were examined. Intervention: Subjects underwent a physical exam; fasting blood samples for androgens, gonadotropins, and metabolic parameters; and a transvaginal ultrasound. Main Outcome Measures: The phenotype was compared between groups. Results: Ninety-seven percent of women with IM/HA had PCOM. Therefore, the groups with and without PCOM were combined. The Ferriman-Gallwey score and androgen levels were highest in the hyperandrogenic groups (IM/HA and HA/PCOM), whereas ovarian volume was higher in all PCOS subgroups compared with controls, as expected based on the definitions of the PCOS subgroups. Body mass index and insulin levels were highest in the IM/HA subgroup. Conclusions: Subjects with PCOS defined by IM/HA are the most severely affected women on the basis of androgen levels, ovarian volumes, and insulin levels. Their higher body mass index partially accounts for the increased insulin levels, suggesting that weight gain exacerbates the symptoms of PCOS.</abstract><cop>Bethesda, MD</cop><pub>Endocrine Society</pub><pmid>17003085</pmid><doi>10.1210/jc.2006-1327</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-972X
ispartof The journal of clinical endocrinology and metabolism, 2006-12, Vol.91 (12), p.4842-4848
issn 0021-972X
1945-7197
language eng
recordid cdi_proquest_miscellaneous_68224401
source Oxford Journals Online
subjects Adolescent
Adult
Androgens - blood
Biological and medical sciences
Body Mass Index
Body Weight - physiology
Endocrinopathies
Female
Fundamental and applied biological sciences. Psychology
Gonadotropins - blood
Hormones - blood
Humans
Medical sciences
Metabolic Syndrome - blood
Metabolic Syndrome - epidemiology
Metabolism - physiology
Middle Aged
Phenotype
Physical Examination
Polycystic Ovary Syndrome - classification
Vertebrates: endocrinology
title Characterizing Discrete Subsets of Polycystic Ovary Syndrome as Defined by the Rotterdam Criteria: The Impact of Weight on Phenotype and Metabolic Features
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T15%3A16%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterizing%20Discrete%20Subsets%20of%20Polycystic%20Ovary%20Syndrome%20as%20Defined%20by%20the%20Rotterdam%20Criteria:%20The%20Impact%20of%20Weight%20on%20Phenotype%20and%20Metabolic%20Features&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=Welt,%20C.%20K.&rft.date=2006-12-01&rft.volume=91&rft.issue=12&rft.spage=4842&rft.epage=4848&rft.pages=4842-4848&rft.issn=0021-972X&rft.eissn=1945-7197&rft.coden=JCEMAZ&rft_id=info:doi/10.1210/jc.2006-1327&rft_dat=%3Cproquest_cross%3E68224401%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c401t-e3d25736b2baf9660ae8761fd06ce2260d155757677a63ca481c75df217200fa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68224401&rft_id=info:pmid/17003085&rfr_iscdi=true